97205 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells Stomach, Intestines
Chimeric, human and humanized anti-CSAp monoclonal antibodies
#602Anti-human DLL4 antibodies and compositions
#603Antibody-drug conjugates and methods
#604TREATMENT WITH ANTI-VEGF ANTIBODIES
#605Genetic products differentially expressed in tumors and the use thereof
#606TREATMENT WITH ANTI-VEGF ANTIBODIES
#607Antibodies to non-functional P2Xreceptor
#608Antibodies to notch receptors
#609Chimeric, human and humanized anti-CSAP monoclonal antibodies
#610Use of Pegylated IL-10 to Treat Cancer
#611Variants of humanized anti-carcinoma MAb CC49
#612Extending survival of cancer patients with elevated levels of EGF or TGF-alpha
#613Neoplasm specific antibodies and uses thereof
#614Cancer Therapeutic
#615Treatment with anti-VEGF antibodies
#616Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#617Bifunctional energy-reversible acyl-compositions
#618TREATMENT WITH ANTI-VEGF ANTIBODIES
#619TREATMENT WITH ANTI-VEGF ANTIBODIES
#620TREATMENT WITH ANTI-VEGF ANTIBODIES
#621TREATMENT WITH ANTI-VEGF ANTIBODIES
#622Novel compounds
#623TAT- 001 and methods of assessing and treating cancer
#624Ovr115 antibody compositions and methods of use
#625TREATMENT WITH ANTI-VEGF ANTIBODIES
#626TREATMENT WITH ANTI-VEGF ANTIBODIES
#627TREATMENT WITH ANTI-VEGF ANTIBODIES
#628Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer
#629TREATMENT WITH ANTI-VEGF ANTIBODIES
#630TREATMENT WITH ANTI-VEGF ANTIBODIES
#631TREATMENT WITH ANTI-VEGF ANTIBODIES
#632Cancerous disease modifying antibodies
#633Cancerous disease modifying antibodies
#634TREATMENT WITH ANTI-VEGF ANTIBODIES
#635TREATMENT WITH ANTI-VEGF ANTIBODIES
#636Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#637Antibodies and related molecules that bind to 161P2F10B proteins
#638Immunotherapy of rectal cancer
#639Elimination of heterogeneous or mixed cell population in tumors
#640Use of specified tcf target genes to identify drugs for the treatment of cancer in particular colorectal cancer in which tcf/ss-cateini/wnt signalling plays a central role
#641Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain
#642Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
#643Bifunctional energy-reversible acyl-compositions
#644Production and use of novel peptide-based agents for use with bi-specific antibodies
#645Humanized anti-5T4 antibodies and anti-5T4/calicheamicin conjugates
#646Methods for diagnosis and prognosis of cancer
#647Neoplasm specific antibodies and uses thereof
#648Survivin, a protein that inhibits cellular apoptosis, and its modulation
#649Survivin, a protein that inhibits cellular apoptosis, and its modulation
#650Efficient production of IgM in recombinant mammalian cells
#651Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
#652Antibody recognizing antibody
#653Genetic products differentially expressed in tumors and the use thereof
#654Production and use of novel peptide-based agents with bispecific antibodies
#655Genes and polypeptides relating to hepatocellular or colorectal carcinoma
#656Secreted and transmembrane polypeptides and nucleic acids encoding the same
#657Antibody-drug conjugates and methods
#658Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#659Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#660Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
#661Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
#662Production of biomedical peptides and proteins in plants using plant virus vectors
#663Detection of CDX2 expression
#664Cancerous disease modifying antibodies
#665Treatment with anti-VEGF antibodies
#666Variants of humanized anti-carcinoma monoclonal antibody CC49
#667Reagents and methods useful for detecting diseases of the gastrointestinal tract
#668Chimeric, human and humanized anti-CSAp monoclonal antibodies
#669Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#670Reagents and methods useful for detecting diseases of the gastrointestinal tract
#671Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides
#672Survivin, a protein that inhibits cellular apoptosis, and its modulation
#673Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides
#674Recombinant immunoreceptors
#675Method of diagnosing, monitoring, staging, imaging and treating colon cancer
#676Host cells containing multiple integrating vectors
#677Cytotoxicity mediation of cells evidencing surface expression of MCSP
#678Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#679Cancerous disease modifying antibodies
#680Cancer diagnostics
#681Cancerous disease modifying antibodies
#682Therapeutic and diagnostic conjugates for use with multispecific antibodies
#683Cancerous disease modifying antibodies
#684Anti-cancer antibodies, combination therapies, and uses thereof